Cite
The organometallic ferrocene exhibits amplified anti-tumor activity by targeted delivery via highly selective ligands to αvβ3, αvβ6, or α5β1 integrins
MLA
Markus Nieberler, et al. The Organometallic Ferrocene Exhibits Amplified Anti-Tumor Activity by Targeted Delivery via Highly Selective Ligands to Αvβ3, Αvβ6, or Α5β1 Integrins. Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2c9751106f01b560e0c36b2a762555bb&authtype=sso&custid=ns315887.
APA
Markus Nieberler, Anke Benge, Francesco Saverio Di Leva, Fritz E. Kühn, Susanne Kossatz, Beatrice Stefanie Ludwig, Salvatore Di Maro, Ute Reuning, Luciana Marinelli, Stefano Tomassi, Horst Kessler, & Florian Reichart. (2021). The organometallic ferrocene exhibits amplified anti-tumor activity by targeted delivery via highly selective ligands to αvβ3, αvβ6, or α5β1 integrins.
Chicago
Markus Nieberler, Anke Benge, Francesco Saverio Di Leva, Fritz E. Kühn, Susanne Kossatz, Beatrice Stefanie Ludwig, Salvatore Di Maro, et al. 2021. “The Organometallic Ferrocene Exhibits Amplified Anti-Tumor Activity by Targeted Delivery via Highly Selective Ligands to Αvβ3, Αvβ6, or Α5β1 Integrins,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2c9751106f01b560e0c36b2a762555bb&authtype=sso&custid=ns315887.